U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Factor V deficiency

MedGen UID:
1369551
Concept ID:
C4317320
Disease or Syndrome
Synonym: Reduced coagulation factor V activity
SNOMED CT: Factor V deficiency (4320005)
 
HPO: HP:0003225
Monarch Initiative: MONDO:0020586
OMIM®: 612309

Disease characteristics

Excerpted from the GeneReview: Factor V Leiden Thrombophilia
Factor V Leiden thrombophilia is characterized by venous thromboembolism (VTE) manifesting most commonly in adults as deep vein thrombosis (DVT) in the legs or pulmonary embolism. Thrombosis in unusual locations is less common. Factors that predispose to VTE in factor V Leiden thrombophilia include: the number of factor V Leiden variant alleles (homozygotes have a much greater thrombotic risk); family history of VTE; presence of coexisting genetic thrombophilic disorders; acquired thrombophilic disorders (e.g., antiphospholipid antibody syndrome, paroxysmal nocturnal hemoglobinuria, myeloproliferative disorders); and circumstantial risk factors (e.g., pregnancy, malignancy, central venous catheters, travel, combined oral contraceptive use and other combined contraceptives, oral hormone replacement therapy [HRT], obesity, leg injury, and advancing age). [from GeneReviews]
Full text of GeneReview (by section):
Summary  |  Diagnosis  |  Clinical Characteristics  |  Differential Diagnosis  |  Management  |  Genetic Counseling  |  Resources  |  Molecular Genetics  |  Chapter Notes  |  References
Authors:
Daniele Pastori  |  Danilo Menichelli  |  Emanuele Valeriani, et. al.   view full author information

Conditions with this feature

Congenital factor V deficiency
MedGen UID:
4633
Concept ID:
C0015499
Disease or Syndrome
Factor V deficiency is a rare autosomal recessive bleeding disorder with variable phenotypic expression (summary by van Wijk et al., 2001).
Factor V and factor VIII, combined deficiency of, with normal protein C and protein C inhibitor
MedGen UID:
346462
Concept ID:
C1856882
Disease or Syndrome
Factor 5 and Factor VIII, combined deficiency of, 2
MedGen UID:
462239
Concept ID:
C3150889
Disease or Syndrome
Combined deficiency of factor V and factor VIII type 2 (F5F8D2) is characterized by bleeding symptoms similar to those in hemophilia (306700) or parahemophilia (227400), caused by single deficiency of FV (612309) or FVIII (300841), respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma FV and FVIII antigen and activity levels are in the range of 5 to 30%. Inheritance of F5F8D2 is autosomal recessive and distinct from the coinheritance of FV deficiency and FVIII deficiency (summary by Zhang and Ginsburg, 2004). For a general phenotypic description and a discussion of genetic heterogeneity of F5F8D, see 227300.
Factor V and factor VIII, combined deficiency of, type 1
MedGen UID:
1637212
Concept ID:
C4551981
Disease or Syndrome
Combined deficiency of factor V and factor VIII (F5F8D1) is characterized by bleeding symptoms similar to those in hemophilia (306700) or parahemophilia (227400), caused by single deficiency of factor V (612309) or factor VIII (300840), respectively. The most common symptoms are epistaxis, menorrhagia, and excessive bleeding during or after trauma. Plasma FV and FVIII antigen and activity levels are in the range of 5 to 30%. Inheritance of F5F8D is autosomal recessive and distinct from the coinheritance of FV deficiency and FVIII deficiency (summary by Zhang and Ginsburg, 2004). Genetic Heterogeneity of Combined Deficiency of Factor V and Factor VIII Another form of combined deficiency of factor V and factor VIII (F5F8D2; 613625) is caused by mutation in the MCFD2 gene (607788) on chromosome 2p21.
Congenital disorder of glycosylation, type IIw
MedGen UID:
1794196
Concept ID:
C5561986
Disease or Syndrome
Congenital disorder of glycosylation type IIw (CDG2W) is an autosomal dominant metabolic disorder characterized by liver dysfunction, coagulation deficiencies, and profound abnormalities in N-glycosylation of serum specific proteins. All reported patients carry the same mutation (602671.0017) (summary by Ng et al., 2021). For an overview of congenital disorders of glycosylation, see CDG1A (212065) and CDG2A (212066).

Professional guidelines

PubMed

De Pablo-Moreno JA, Miguel-Batuecas A, Rodríguez-Merchán EC, Liras A
Thromb Res 2023 Nov;231:99-111. Epub 2023 Oct 6 doi: 10.1016/j.thromres.2023.10.001. PMID: 37839151
Vasudevan B, Neema S, Verma R
Indian J Dermatol Venereol Leprol 2016 Sep-Oct;82(5):478-88. doi: 10.4103/0378-6323.183635. PMID: 27297279
Gallus AS
Semin Thromb Hemost 2005 Feb;31(1):118-26. doi: 10.1055/s-2005-863814. PMID: 15706484

Curated

UK NICE Guideline NG158, Venous thromboembolic diseases: diagnosis, management and thrombophilia testing, 2023

Suggested Reading

PubMed

Bhatt S, Taylor AK, Lozano R, Grody WW, Griffin JH; ACMG Professional Practice and Guidelines Committee
Genet Med 2021 Dec;23(12):2463. Epub 2021 Mar 5 doi: 10.1038/s41436-021-01108-x. PMID: 33674767

Recent clinical studies

Etiology

Fehdi MA, Lazraq M, Benhamza S, Bensaid A, Miloudi Y, Harrar NE
Pan Afr Med J 2020;36:46. Epub 2020 May 29 doi: 10.11604/pamj.2020.36.46.23561. PMID: 32774622Free PMC Article
Huang JN, Koerper MA
Haemophilia 2008 Nov;14(6):1164-9. doi: 10.1111/j.1365-2516.2008.01785.x. PMID: 19141156
Knöbl P, Lechner K
Baillieres Clin Haematol 1998 Jun;11(2):305-18. doi: 10.1016/s0950-3536(98)80050-4. PMID: 10097809
Wu KK
J Cardiovasc Risk 1997 Oct-Dec;4(5-6):347-52. PMID: 9865665
Griffin JH, Heeb MJ, Kojima Y, Fernández JA, Kojima K, Hackeng TM, Greengard JS
Thromb Haemost 1995 Jul;74(1):444-8. PMID: 8578503

Diagnosis

Yang J, Mao H, Sun L
J Clin Lab Anal 2022 Nov;36(11):e24705. Epub 2022 Sep 20 doi: 10.1002/jcla.24705. PMID: 36125894Free PMC Article
Jain S, Acharya SS
Transfus Apher Sci 2019 Oct;58(5):572-577. Epub 2019 Aug 8 doi: 10.1016/j.transci.2019.08.007. PMID: 31427261
Tabibian S, Shiravand Y, Shams M, Safa M, Gholami MS, Heydari F, Ahmadi A, Rashidpanah J, Dorgalaleh A
Semin Thromb Hemost 2019 Jul;45(5):523-543. Epub 2019 May 23 doi: 10.1055/s-0039-1687906. PMID: 31121608
Thalji N, Camire RM
Semin Thromb Hemost 2013 Sep;39(6):607-12. Epub 2013 Jul 26 doi: 10.1055/s-0033-1349224. PMID: 23893775
Lippi G, Favaloro EJ, Montagnana M, Manzato F, Guidi GC, Franchini M
Blood Coagul Fibrinolysis 2011 Apr;22(3):160-6. doi: 10.1097/MBC.0b013e3283424883. PMID: 21245750

Therapy

De Pablo-Moreno JA, Miguel-Batuecas A, Rodríguez-Merchán EC, Liras A
Thromb Res 2023 Nov;231:99-111. Epub 2023 Oct 6 doi: 10.1016/j.thromres.2023.10.001. PMID: 37839151
Jain S, Acharya SS
Transfus Apher Sci 2019 Oct;58(5):572-577. Epub 2019 Aug 8 doi: 10.1016/j.transci.2019.08.007. PMID: 31427261
Spreafico M, Peyvandi F
Haemophilia 2008 Nov;14(6):1201-8. doi: 10.1111/j.1365-2516.2008.01845.x. PMID: 19141160
Huang JN, Koerper MA
Haemophilia 2008 Nov;14(6):1164-9. doi: 10.1111/j.1365-2516.2008.01785.x. PMID: 19141156
Knöbl P, Lechner K
Baillieres Clin Haematol 1998 Jun;11(2):305-18. doi: 10.1016/s0950-3536(98)80050-4. PMID: 10097809

Prognosis

Ichinose A, Osaki T, Souri M
Semin Thromb Hemost 2022 Mar;48(2):206-218. Epub 2021 Dec 23 doi: 10.1055/s-0041-1740149. PMID: 34942668
Yamanishi M, Nishimi Y, Usui M, Miki K, Imashuku S
Clin Lab 2019 Oct 1;65(10) doi: 10.7754/Clin.Lab.2019.190240. PMID: 31625361
Knöbl P, Lechner K
Baillieres Clin Haematol 1998 Jun;11(2):305-18. doi: 10.1016/s0950-3536(98)80050-4. PMID: 10097809
Girolami A, Simioni P, Scarano L, Girolami B, Marchiori A
Blood Rev 1998 Mar;12(1):45-51. doi: 10.1016/s0268-960x(98)90029-7. PMID: 9597197
Griffin JH, Heeb MJ, Kojima Y, Fernández JA, Kojima K, Hackeng TM, Greengard JS
Thromb Haemost 1995 Jul;74(1):444-8. PMID: 8578503

Clinical prediction guides

Tabibian S, Shiravand Y, Shams M, Safa M, Gholami MS, Heydari F, Ahmadi A, Rashidpanah J, Dorgalaleh A
Semin Thromb Hemost 2019 Jul;45(5):523-543. Epub 2019 May 23 doi: 10.1055/s-0039-1687906. PMID: 31121608
Spreafico M, Peyvandi F
Semin Thromb Hemost 2009 Jun;35(4):390-9. Epub 2009 Jul 13 doi: 10.1055/s-0029-1225761. PMID: 19598067
Duckers C, Simioni P, Rosing J, Castoldi E
Br J Haematol 2009 Jun;146(1):17-26. Epub 2009 Apr 27 doi: 10.1111/j.1365-2141.2009.07708.x. PMID: 19438479
Spreafico M, Peyvandi F
Haemophilia 2008 Nov;14(6):1201-8. doi: 10.1111/j.1365-2516.2008.01845.x. PMID: 19141160
Griffin JH, Heeb MJ, Kojima Y, Fernández JA, Kojima K, Hackeng TM, Greengard JS
Thromb Haemost 1995 Jul;74(1):444-8. PMID: 8578503

Recent systematic reviews

Spiliopoulos D, Kadir RA
Blood Coagul Fibrinolysis 2016 Apr;27(3):237-41. doi: 10.1097/MBC.0000000000000407. PMID: 26376169
Kulkarni BP, Nair SB, Vijapurkar M, Mota L, Shanbhag S, Ali S, Shetty SD, Ghosh K
PLoS One 2014;9(9):e108683. Epub 2014 Oct 2 doi: 10.1371/journal.pone.0108683. PMID: 25275492Free PMC Article
Streiff MB, Ness PM
Transfusion 2002 Jan;42(1):18-26. doi: 10.1046/j.1537-2995.2002.00011.x. PMID: 11896308

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Curated

    • NICE, 2023
      UK NICE Guideline NG158, Venous thromboembolic diseases: diagnosis, management and thrombophilia testing, 2023

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...